Lv7
4380 积分 2023-03-27 加入
Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy
16小时前
已完结
Targeting the master of the replication fork—PCNA
12天前
已完结
Development of Novel PROTAC RAD51 Degraders as Enhancers of DNA Damage Response for Hepatocellular Carcinoma Treatment
20天前
已完结
Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective
25天前
已完结
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
1个月前
已完结
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy
1个月前
已完结
RIPTACs: A groundbreaking approach to drug discovery
1个月前
已完结
Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the ‘Undruggable’ MYC Oncogene and Potentiate Immune Checkpoint Blockage
2个月前
已完结
Targeting the TRIB3–MYC axis in cancer: mechanistic insights and therapeutic disruption strategies
2个月前
已完结
Flourishing innovation in KRAS targeting: Recent advances in medicinal chemistry strategies and future perspectives
2个月前
已完结
皖公网安备34019202002308
